Revance Therapeutics, Inc. Quarterly Quick Ratio in % from Q1 2021 to Q2 2024

Taxonomy & unit
ratio: %
Description
The acid-test ratio, also called the quick ratio, is a metric used to see if a company is positioned to sell assets within 90 days to meet immediate expenses.
Summary
Revance Therapeutics, Inc. quarterly Quick Ratio history and growth rate from Q1 2021 to Q2 2024.
  • Revance Therapeutics, Inc. Quick Ratio for the quarter ending June 30, 2024 was 63 %, a 95% increase year-over-year.
Quick Ratio, Quarterly (%)
Quick Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 63 +30.7 +95% Jun 30, 2024
Q1 2024 56.2 +31 +123% Mar 31, 2024
Q4 2023 47.6 +27.6 +138% Dec 31, 2023
Q3 2023 40.9 +23.1 +130% Sep 30, 2023
Q2 2023 32.3 +16.5 +104% Jun 30, 2023
Q1 2023 25.2 +11.4 +83% Mar 31, 2023
Q4 2022 20 +7.19 +56.1% Dec 31, 2022
Q3 2022 17.8 +6.43 +56.7% Sep 30, 2022
Q2 2022 15.9 +7.06 +80.3% Jun 30, 2022
Q1 2022 13.7 +6.46 +88.8% Mar 31, 2022
Q4 2021 12.8 Dec 31, 2021
Q3 2021 11.3 Sep 30, 2021
Q2 2021 8.79 Jun 30, 2021
Q1 2021 7.28 Mar 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.